MAR 04, 2016 08:13 AM PST

New Antiviral Drug Beats Ebola Virus in Monkey Trials

WRITTEN BY: Xuan Pham
Ebola virus

A new small-molecule drug was recently shown to protect Rhesus monkeys from the Ebola virus, decreasing viral loads significantly and resulting in 100% survival of the monkeys. This compound was also shown to successfully treat 2 human Ebola patients for whom the drug was given for compassionate use. These results make the compound GS-5734 a likely pharmaceutical candidate for Ebola treatment.
 
Ebola infection and transmission caused a huge international health crisis in 2015 in West Africa, the site of the largest outbreak in history. The virus causes severe hemorrhagic fevers that lead to high mortality rates, since there are no licensed vaccines or therapies against this virus. While the outbreak is currently under control, there’s no guarantee that such event won’t be repeated. As such, research into possible Ebola treatment is imperative.
 
 
The small-molecule compound is described as a nucleotide analog prodrug, inhibiting the incorporation of the adenosine base in the viral DNA. This effectively “blocks the virus's ability to replicate its own genetic material,” said first study author, Travis Warren. "With this process inhibited, the virus can't make copies of itself. Additionally, we saw no evidence from genetic sequence analyses that the virus was able to generate resistance to GS-5734," he added.
 
In Rhesus monkeys treated with the GS-5734 compound within 3 days after infection, the researchers noticed remission of physical Ebola symptoms and decreased viral load count. Remarkably, these treated monkeys showed 100% survival after infection, showing promising evidence of the efficacy of this drug.
 
GS-5734 has also shown to be effective in cells grown on laboratory dishes. In these systems, the compound was active against a broad spectrum of viral pathogens, including multiple strains of the Ebola virus, as well as Middle East Respiratory Syndrome (MERS) virus, and Marburg virus. These additional results could extend the application of the compound to treating multiple other viral-associated diseases.
 
"GS-5734 has several favorable characteristics for potential treatment of Ebola virus disease in humans. It is made using well-controlled chemical synthesis procedures, is stable, and can be made on a large scale," said Sina Bavari, senior study author. "It shows substantive post-exposure protection against Ebola virus in nonhuman primates, even when treatments were started after virus had spread to the blood in some animals."
 
The research team is excited at the prospects of conducting further testing on this compound. Already, Gilead Sciences, a prominent collaborator in this study, is conducting a phase I clinical trial with GS-5734 to determine safety and pharmacokinetic properties in healthy human patients.
 
In two instances where the compound was given to patients for compassionate use, both patients recovered fully and were discharged from the hospitals. How GS-5734 played a role in the recovery will be extensively studied in the future.
 
Additional source: Nature journal,  Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Clinical & Molecular DX
APR 24, 2018
An Atlas of the Human Genome
Scientists from the Hebrew University of Jerusalem want to identify individual genes responsible for specific diseases. This goal inspired their new Nature...
APR 25, 2018
Clinical & Molecular DX
APR 25, 2018
Why is dementia going unnoticed in hospitals?
A study in the UK showed that while the rate of diagnosis for dementia is improving, more than a third of all dementia patients still go undiagnosed. The n...
APR 29, 2018
Genetics & Genomics
APR 29, 2018
CRISPR Can Now Edit Genes Outside of the Cell
The CRISPR/Cas9 gene-editing tool was made from an immune defense system used by bacteria. Scientists have found it has many applications....
AUG 11, 2018
Microbiology
AUG 11, 2018
A Microbrewery can Help us Monitor Radiation Exposure
This wearable technology is very sensitive, and can be used by workers that are at risk of radiation exposure....
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Nanotech patch makes light-up medical tests 100x brighter
Researchers have developed a high-tech fix that uses metal nanostructures to increase the fluorescence intensity by 100 times in diagnostic tests. It&rsquo...
OCT 17, 2018
Cell & Molecular Biology
OCT 17, 2018
Saving Patients From Unnecessary Chemotherapy with a Blood Test
Often, cancer patients get chemotherapy after surgery to ensure that their cancer will not come back; for many it's not needed....
Loading Comments...